| Summary: | Abstract Background Since walking is a daily activity not to require the maximal effort in healthy populations, a very few universal bio-parameters and/or methods have been defined to evaluate individual walking characteristics in those populations. A concept of “economy” is a potential candidate; however, walking economy highly depends on speed, so direct comparisons of economy values are difficult between studies. We investigated whether the vertical component of net walking “efficiency” (Effvert; %) is constant across speed. In that case, direct comparisons of Effvert will be possible between studies or individuals at any voluntary speed. Methods Thirty young male participants walked at eight speeds on the level or ± 5% gradients, providing vertical speeds (v vert). Differences in energy expenditure between level and uphill or downhill gradients (ΔEE) were calculated. The metabolic rate for vertical component (MRvert) was calculated by multiplying ΔEE with body mass (BM). The mechanical power output for vertical component (Pmech) was calculated by multiplying BM, gravitational acceleration, and v vert. Effvert was obtained from the ratio of Pmech to MRvert at each v vert. Delta efficiency (Delta-E; %) was also calculated from the inverse slope of the regression line representing the relationship of Pmech to MRvert. Results Upward Effvert was nearly constant at around 35% and downward Effvert ranged widely (49–80%). No significant differences were observed between upward Delta-E (35.5 ± 8.8%) and Effvert at any speeds, but not between downward Delta-E (44.9 ± 12.8%) and Effvert. Conclusions Upward ΔEE could be proportional to v vert. Upward, but not downward, Effvert should be useful not only for healthy populations but also for clinical patients to evaluate individual gait characteristics, because it requires only two metabolic measurements on the level and uphill gradients without kinematic information at any voluntary speed. Trial registration UMIN000017690 (R000020501; registered May 26th, 2015, before the first trial) and UMIN000031456 (R000035911; registered Feb. 23rd, 2018, before the first trial).
|
|---|
